標(biāo)題: Titlebook: Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology; Seth Kwabena Amponsah,Yashwant V. Pathak Book 2022 The Editor(s) ( [打印本頁(yè)] 作者: 鳥場(chǎng) 時(shí)間: 2025-3-21 16:07
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology影響因子(影響力)
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology影響因子(影響力)學(xué)科排名
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology網(wǎng)絡(luò)公開度
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology被引頻次
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology被引頻次學(xué)科排名
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology年度引用
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology年度引用學(xué)科排名
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology讀者反饋
書目名稱Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology讀者反饋學(xué)科排名
作者: 畏縮 時(shí)間: 2025-3-21 22:45
http://image.papertrans.cn/r/image/823025.jpg作者: Diluge 時(shí)間: 2025-3-22 03:21
https://doi.org/10.1007/978-3-031-12398-6pharmacokinetics; drug dose adjustment; pharmacogenomics; biological matrices; critical care drug dosage作者: 男生戴手銬 時(shí)間: 2025-3-22 08:24
Seth Kwabena Amponsah,Yashwant V. PathakFills a gap in published literature on specifics of TDM and Toxicity.Covers forensic toxicology, nanotoxicology, toxicogenomics and toxinology.Discusses pharmacokinetics and pharmacogenomics作者: OCTO 時(shí)間: 2025-3-22 11:24 作者: 圓柱 時(shí)間: 2025-3-22 14:57 作者: MELON 時(shí)間: 2025-3-22 18:09
Plasma Therapeutic Drug Monitoring and Clinical Toxicology, bloodstream. The ability to predict a drug concentration within the serum or plasma following a predetermined dose is essential in treating disease; however, a given dose of a drug may not produce identical serum concentrations between patients due to variations in drug formulation, drug interactio作者: 嘴唇可修剪 時(shí)間: 2025-3-23 01:11 作者: 惹人反感 時(shí)間: 2025-3-23 02:14 作者: exhilaration 時(shí)間: 2025-3-23 07:38 作者: CLEAR 時(shí)間: 2025-3-23 13:35
Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices,herapeutic drug monitoring (TDM) have, on the other hand, remained underappreciated. TDM has the potential to enhance patient outcomes while also lowering healthcare expenditures due to its unambiguous dose-response correlations. Two new approaches to TDM have emerged in recent years: target concent作者: 粗鄙的人 時(shí)間: 2025-3-23 16:47 作者: 制定 時(shí)間: 2025-3-23 20:07
Reducing Toxicity in Critically Ill Patients by Using Therapeutic Drug Monitoring,ualization, we can minimize the toxicity in critically ill patients. These days, the patient and organism complexity demand precision dosing which can be achieved through therapeutic drug monitoring (TDM) services. TDM has proven to be an effective approach for dose individualization. Conventionally作者: Estrogen 時(shí)間: 2025-3-24 00:32 作者: GREEN 時(shí)間: 2025-3-24 03:08 作者: 手段 時(shí)間: 2025-3-24 09:08 作者: Abnormal 時(shí)間: 2025-3-24 12:44
Therapeutic Drug Monitoring and Toxicology: Relevance of Measuring Metabolites,taining drug concentrations below toxic levels. Although TDM has predominantly focused on determining the level of the parent drug compound in order to guide the dosing regimen, it is important to consider that some drugs are inactive in their parental forms and only their metabolites have therapeut作者: 墊子 時(shí)間: 2025-3-24 16:54
Recent Advances in Nanosensors for Therapeutic Drug Monitoring (TDM),rials and nanotechnology for therapeutic drug monitoring (TDM) in order to meet the urgent need of measuring drug concentrations in biological matrices like plasma, serum, saliva, or urine, at a lower cost and within a shorter time period than traditional immunoassays or chromatographic methods. Dev作者: exacerbate 時(shí)間: 2025-3-24 21:27
,Organ Toxicity by?Immunosuppressive Drugs in Solid Organ Transplantation,nction and provides improved quality of life together with its cost-effectiveness. During perioperative and post-transplant periods, organ transplant recipients receive immunosuppressive therapy, which reduces the high risk of allograft rejection, minimizes infections, improves allograft quality, an作者: 熱烈的歡迎 時(shí)間: 2025-3-25 01:06 作者: inculpate 時(shí)間: 2025-3-25 04:12 作者: 清澈 時(shí)間: 2025-3-25 11:13 作者: assent 時(shí)間: 2025-3-25 12:05 作者: Largess 時(shí)間: 2025-3-25 17:22
Therapeutic and Toxic Concentrations of Drugs in Biological Matrices,ually, when drug levels in these matrices attain toxic concentrations, it will lead to potential adverse effects, thus the need for documented data on therapeutic and toxic concentrations of drugs in the various biological matrices.作者: AVID 時(shí)間: 2025-3-25 23:22
Analyzing Data from Therapeutic Drug Monitoring, Pharmacokinetics, and Clinical Toxicology Studies, such high standards that the integrity of conclusions drawn from it cannot be disputed. This chapter describes key concepts and provides practical examples on planning, handling, and analyzing data in therapeutic drug monitoring, pharmacokinetics and clinical toxicology studies.作者: miscreant 時(shí)間: 2025-3-26 04:05
Drug Dose and Therapy Individualization,are. This chapter explores the effects of patients’ comorbidities and pharmacogenetics, specifically in regard to cytochrome P450 (CYP450) metabolism, infection, obesity, and renal insufficiency in order to highlight how important it is to understand a patient’s individualism when prescribing based on treatment algorithms.作者: 表示向下 時(shí)間: 2025-3-26 04:19 作者: 玩忽職守 時(shí)間: 2025-3-26 09:11
Models for Drug Individualization: Patient to Population Level,ing (PBPK) have been developed in order to gradually replace large and expensive clinical studies. By understanding how pharmacotherapy differs between individuals and populations, clinicians can begin to optimize drug therapy, taking the next step forward into personalized medicine which will?optimize drug efficacy and safety.作者: 浪費(fèi)時(shí)間 時(shí)間: 2025-3-26 15:58
Artificial Intelligence-Based Techniques to Assess Drug Toxicity in Drug-Induced Liver Injury (DILIgnosing DILI injury patterns, liver toxicity, and disease management. Deep learning models in artificial intelligence can be tested on the whole slide digital images (WSI) of liver biopsy to classify the DILI injury patterns such as fibrosis and steatosis.作者: 盡管 時(shí)間: 2025-3-26 19:17
gy.Discusses pharmacokinetics and pharmacogenomics.This book gives an overview of therapeutic drug monitoring (TDM) and its clinical application. It also highlights recent advances in toxicological studies, as they relate to therapeutic drug monitoring.??.This is one of the few books available on th作者: 物質(zhì) 時(shí)間: 2025-3-26 21:33 作者: Fibrillation 時(shí)間: 2025-3-27 03:22 作者: 不能平靜 時(shí)間: 2025-3-27 05:25 作者: 漫步 時(shí)間: 2025-3-27 12:25 作者: cultivated 時(shí)間: 2025-3-27 13:47
Gregory Fishberger,Nicole Natarelli,Dao Le,Deborah Liaw,Afrin Naz,Caroline Ward,Michael Young,Charletiations. It concluded agreements with Japan to export military-related high-technology goods to the U.S., to transfer highly advanced technologies from Japan to the United States through cooperative research, and to transform the Japanese institutional structures. The United States efforts to trans作者: Exposition 時(shí)間: 2025-3-27 20:42 作者: 設(shè)施 時(shí)間: 2025-3-27 22:14
Surovi Saikia,Jinga B. Prajapati,Bhupendra G. Prajapati,Vijaya V. Padma,Yashwant V. Pathaktiations. It concluded agreements with Japan to export military-related high-technology goods to the U.S., to transfer highly advanced technologies from Japan to the United States through cooperative research, and to transform the Japanese institutional structures. The United States efforts to trans作者: 先兆 時(shí)間: 2025-3-28 03:21 作者: 毗鄰 時(shí)間: 2025-3-28 08:26
Biswajit Basu,Bhupendra G. Prajapati,Swarupananda Mukherjee,Tapas Kumar Roy,Arnab Roy,Chowdhury Mobae context of the theory of multiple modernities. By doing so, the chapter demonstrates the ‘Europe as modernity’ angle provides a new line of inquiry into the question of Britain’s relationship with ‘Europe’ as well as modernity as British society has experienced it.作者: 豪華 時(shí)間: 2025-3-28 10:35 作者: etiquette 時(shí)間: 2025-3-28 14:36
Zalak Panchal,Khushboo Faldu,Jigna Shahe context of the theory of multiple modernities. By doing so, the chapter demonstrates the ‘Europe as modernity’ angle provides a new line of inquiry into the question of Britain’s relationship with ‘Europe’ as well as modernity as British society has experienced it.作者: MIME 時(shí)間: 2025-3-28 21:16
Samuel O. Bekoe,Samuel Asare-Nkansah,Kwabena F. M. Opuniropean varieties of capitalism are ‘popular’ in nature; in particular, in pursuit of the main theme of this book, it asks whether the identified changes in the broader European political economy are taking capitalism closer to or further from the wishes and control of its citizens. Fundamentally, if作者: 燈泡 時(shí)間: 2025-3-29 02:33
Seema Kohli,Lavakesh Kumar Omrayropean varieties of capitalism are ‘popular’ in nature; in particular, in pursuit of the main theme of this book, it asks whether the identified changes in the broader European political economy are taking capitalism closer to or further from the wishes and control of its citizens. Fundamentally, if作者: 羽毛長(zhǎng)成 時(shí)間: 2025-3-29 05:29 作者: 小步走路 時(shí)間: 2025-3-29 09:31
James Akingbasote,Sandra Szlapinski,Elora Hilmas,Patrik Miller,Natalie Rineropean varieties of capitalism are ‘popular’ in nature; in particular, in pursuit of the main theme of this book, it asks whether the identified changes in the broader European political economy are taking capitalism closer to or further from the wishes and control of its citizens. Fundamentally, if作者: propose 時(shí)間: 2025-3-29 15:22 作者: 皮薩 時(shí)間: 2025-3-29 18:48
George J. Dugbartey,Alp Senerg civic achievement. Enterprise is another key bourgeois virtue and to invoke regional Europe is also to invoke the dynamic Europe implied by the use of the prefix ‘motor’ to describe a grouping of four of the most successful regions — Baden-Württemberg, Rh?ne-Alpes, Lombardy, as well as Catalonia..作者: 競(jìng)選運(yùn)動(dòng) 時(shí)間: 2025-3-29 23:46
Munish Purieir functions transferred to central government or to inter-municipal cooperative boards. Similar debates occurred in the other Nordic countries, apart from in Finland where a directly elected intermediate level had never been established (Sandberg and St?hlberg 2000; Rose and St?hlberg 2005; Sandbe作者: hauteur 時(shí)間: 2025-3-30 00:14
Ashley Mason,Gavin Lockard,Vance Cantrell,Snow Pinxue Li,Kirtan Patel,Sierra Klein,Andre Elder,Melissecting and profound political and cultural conflicts triggered by the economic upheavals, which led to the emergence of an extremely dynamic and unstable transnational digital public sphere, where different political and cultural viewpoints collided..978-3-319-86941-4978-3-319-60843-3作者: Encumber 時(shí)間: 2025-3-30 06:23
Sierra Klein,Ashley Mason,Gavin Lockard,Vance Cantrell,Snow Pinxue Li,Kirtan Patel,Andre Elder,Melissecting and profound political and cultural conflicts triggered by the economic upheavals, which led to the emergence of an extremely dynamic and unstable transnational digital public sphere, where different political and cultural viewpoints collided..978-3-319-86941-4978-3-319-60843-3作者: 沖突 時(shí)間: 2025-3-30 11:24 作者: SLUMP 時(shí)間: 2025-3-30 14:07
Analytical Techniques for Therapeutic Drug Monitoring and Clinical Toxicology, seamless workflow. This chapter, thus, discusses the various high-throughput analytical techniques employed in TDM and CT, as well as the challenges associated with their respective applications as reported in the literature. It must be emphasized that consideration for a suitable analytical method作者: 構(gòu)成 時(shí)間: 2025-3-30 20:29
Plasma Therapeutic Drug Monitoring and Clinical Toxicology,ell as age-related changes in drug metabolism, further complicates medication dosing. Therapeutic drug monitoring in the context of each patient serves to address these factors and requires collaboration between pharmacy, nursing, and medical teams.作者: Crater 時(shí)間: 2025-3-30 23:58
Dried Blood Spots in Therapeutic Drug Monitoring and Toxicology,evoted to discussing the implications of blood hematocrit variations (known as the hematocrit factor) and ways to tackle or cope with this pitfall. Finally, this chapter delineates the procedural steps in DBS sampling, recent innovations in DBS sampling, and high-throughput application of same.作者: Projection 時(shí)間: 2025-3-31 02:11 作者: dysphagia 時(shí)間: 2025-3-31 08:40 作者: propose 時(shí)間: 2025-3-31 10:48 作者: Heart-Rate 時(shí)間: 2025-3-31 17:25
Reducing Toxicity in Critically Ill Patients by Using Therapeutic Drug Monitoring,inetic/pharmacodynamic (PK/PD) target selection, and dosage optimization procedures. The goal of this chapter is to examine available information on TDM practices for different drug classes and to illustrate how TDM might be useful in the reduction of toxicity in critically ill patients with serious作者: PANEL 時(shí)間: 2025-3-31 19:13 作者: 表兩個(gè) 時(shí)間: 2025-4-1 00:52 作者: fidelity 時(shí)間: 2025-4-1 03:30
Therapeutic Drug Monitoring and Toxicology of Immunosuppressant,s goal is to personalize a patient’s drug treatment to achieve the best feasible balance between therapeutic efficacy and the risk of side effects. Due to complicated inter- or intra-patient variability, getting the desired outcome isn’t always as simple as it appears. Monitoring drug levels is crit作者: commute 時(shí)間: 2025-4-1 07:22
Therapeutic Drug Monitoring and Toxicology: Relevance of Measuring Metabolites,ussed, drawing from several examples of drugs that are used in the clinical setting. This chapter emphasizes the utility of TDM of metabolites, demonstrating how select drugs can be converted to reactive metabolites with toxicity potential, and these should be considered when evaluating the efficacy作者: morale 時(shí)間: 2025-4-1 10:56
